Quick Facts: Main Uses

• Targeted Relief: Helps manage infections caused by threadworms (pinworms).
• Therapeutic Goal: Works to eliminate the adult worms present in the gut.
• Household Use: Its use is often recommended for all household members to manage the potential for recurrence.

---

Boots Threadworm is a medication used to manage and address infections caused by threadworms (Enterobius vermicularis), also known as pinworms. Threadworms are small, parasitic worms that can inhabit the human gut and are particularly common in children. This medication functions by acting on the threadworms themselves, which may help relieve the symptoms associated with the infection, such as perianal itching.

For a successful therapeutic outcome, healthcare providers typically advise that all members of the household may benefit from treatment at the same time, even if they show no signs of infection, due to the high likelihood of easy transmission. Because the medicine is thought to eliminate the adult worms but not the eggs, a repeat dose after two weeks may be suggested to assist in preventing re-infection. Patients are also encouraged to maintain strict hygiene measures for several weeks.

The treatment is associated with positive outcomes when combined with these preventative measures. The overall objective is to facilitate resolution of the infection and promote recovery.

Boots Threadworm Treatment, which contains Mebendazole, is suitable for most individuals seeking to treat a threadworm (pinworm) infection.

---

Who Can Use Boots Threadworm Treatment?

The medication is generally safe for use by adults and children over the age of two. The entire household, including those without symptoms, should be treated simultaneously to prevent re-infection.

---

Who Should NOT Use Boots Threadworm Treatment?

There are specific situations where taking this medicine is not recommended. It should not be used by:

• Children under the age of two.
• Individuals with a known allergy or hypersensitivity to Mebendazole or any of the product's other ingredients.
• Women who are pregnant or breastfeeding should consult a doctor or pharmacist before use.
• Individuals with severe liver disease should seek medical advice before beginning treatment.

Consultation with a healthcare professional is essential if you are unsure if the treatment is appropriate for you or a member of your family.

The official regulatory profile for Boots Threadworm Treatment, which contains the active ingredient Mebendazole, details specific required restrictions and pharmacokinetic interaction patterns with other substances.

Documented Drug-Drug Interaction Patterns

The concomitant use of Mebendazole and Metronidazole (an antiprotozoal agent) is officially documented to be avoided by regulatory bodies. This restriction is based on reports suggesting an association between the combination and the occurrence of severe cutaneous reactions, specifically Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).

Other documented interactions are pharmacokinetic, involving effects on Mebendazole's clearance:

• Increased Exposure: Co-administration with Cimetidine (an H2-receptor antagonist) may inhibit Mebendazole's metabolism, which can lead to an increase in Mebendazole plasma concentrations, as described in regulatory summaries.
• Decreased Exposure: Medicines classified as hydantoins, such as Phenytoin and Carbamazepine, may result in a reduction of Mebendazole plasma concentrations.

Administration and Population Notes

The regulatory label indicates that Mebendazole may be taken without regard to food intake. Additionally, official documents note that patients with impaired hepatic function may exhibit higher systemic exposure to Mebendazole, which is an interaction-related consideration tied to the drug’s metabolic route.

Selective Disruption of the Parasite's Cellular Structure

Mebendazole operates by selectively targeting beta-tubulin, a structural protein within the worm's cells, acting as an inhibitor to block its assembly into essential microtubules. This molecular disruption causes the parasite's intestinal structure to collapse, which is the necessary first step toward functional failure.

Catastrophe of Energy Metabolism

The resulting structural damage immediately prevents the worm from absorbing vital nutrients, such as glucose, halting the fundamental energy metabolism pathway. This rapidly depletes the parasite's internal ATP and glycogen stores, leading to its immobilization, cessation of reproductive activity, and subsequent death.

Mechanism Limitation: The Role of Parasitic Resistance

The primary function of the beta-tubulin binding mechanism can be constrained if the worm develops resistance, typically arising from mutations in the gene encoding beta-tubulin. This change in the target protein reduces the drug's binding affinity, thereby allowing the parasite to maintain cellular function and partially bypass the metabolic-failure cascade.

Boots Threadworm tablets contain mebendazole (100 mg), an anthelmintic agent used to treat intestinal worm infections, particularly pinworms (threadworms). The medication works by preventing the worms from absorbing glucose, which leads to their death and expulsion from the body.

Dosage and Administration

The recommended dosage for adults and children aged two years and over is a single 100 mg tablet. Due to the risk of reinfection and transmission, it is noted as important that all members of the household (except for pregnant or breastfeeding women and children under two) be treated simultaneously.

Age Group	Dose	Frequency
Adults & Children (2 years and over)	1 tablet (100 mg)	Single dose

Important Considerations

• The tablet is flavored and may be chewed, crushed, or swallowed whole with a drink of water, juice, or milk, and can be taken with or without food. Crushing the tablet is recommended before administering to a young child.
• A single dose kills the worms, but it does not destroy their eggs. Therefore, a second tablet is often recommended after two weeks to prevent reinfection from hatched eggs.
• Strict hygiene measures, such as frequent handwashing and daily washing of bed linens, should be maintained for two weeks following treatment to further reduce the risk of spreading the infection.
• If symptoms persist or worsen after a few days, a healthcare professional must be consulted.

Research evidence / Overview of studies for Boots Threadworm

Evidence for use in Threadworm Infection (Enterobius vermicularis)

Research explores the use of the active ingredient in Boots Threadworm Treatment for conditions characterized by episodic or acute manifestations caused by threadworm infection. The evidence base includes Randomized Controlled Trials (RCTs) and systematic reviews that pool data from multiple clinical studies. These studies primarily focused on threadworm infection, which is the condition for which this medicine was studied for. Findings describe patterns observed in the studies related to achieving parasite clearance status, which is the high-level endpoint used to measure the presence or absence of the parasite following the study intervention.

---

Study Types and Clinical Endpoints Examined

The studies conducted for the active ingredient range from short-term RCTs, which are highly controlled comparison studies, to long-term post-marketing surveillance that monitors patterns of use in wider populations. Researchers examined core outcomes related to physiological strain caused by the parasite, such as the Egg Reduction Rate (ERR) and the overall parasite clearance status. These metrics contribute to understanding symptom patterns in the observed populations. Studies also explored patient-reported outcomes describing perceived discomfort that was studied for its relationship with the infection.

---

Long-Term Studies and Follow-up

Research exploring short-term symptom changes typically assesses outcomes over defined time intervals. In many studies examining parasite clearance, follow-up durations were limited, often focusing on the immediate post-treatment period, commonly ranging from 10 to 21 days. This provides insight into initial clearance but contributes limited information for long-term outcomes and durability of effect. Evidence suggests that due to the life cycle of the threadworm and the possibility of re-ingestion of eggs, a re-assessment period of approximately two to three weeks was observed in some studies as relevant for defining the overall outcome.

---

Evidence in Special Populations

The active ingredient was evaluated in study populations that included adults and pediatric patients generally two years of age and older. This age range reflects a population where the infection is commonly observed. Research has explored the active ingredient's application in study cohorts including individuals with mixed parasitic infections as well as those with single infections. However, the evidence remains limited and data for certain groups remain insufficient. For instance, safety and clearance status have not been fully established through adequate research in children younger than 2 years of age.

---

Key Limitations and Areas of Research Uncertainty

The existing body of evidence, while substantial for regulatory purposes, highlights areas where research is ongoing or still emerging. One of the main research limitation frames is that sample sizes were modest in some specific trials, and follow-up durations were limited, making it difficult to fully characterize long-term outcomes. Limited information for long-term outcomes is available, and some subgroup findings are uncertain. Evidence highlights what is known — and what is still uncertain, particularly regarding sustained outcomes.

Common questions about Boots Threadworm (FAQ)

Q: Does Boots Threadworm treat other types of worms besides threadworms?

A: The active ingredient, mebendazole, is known to be effective against other types of intestinal worms, including roundworm, whipworm, and hookworm. However, the official over-the-counter (OTC) use for this specific product is primarily for threadworm (pinworm) infection. The product label specifies that treatment for worms other than pinworm is usually restricted to circumstances requiring medical supervision.

Q: How long does Boots Threadworm take to start working?

A: Official pharmacokinetic data, which describes how the body handles the medicine, indicates that the maximum concentration of the active ingredient is generally reached in the bloodstream within 2 to 4 hours after taking the dose. This is a pharmacokinetic measurement that describes when the medicine is absorbed.

Q: Does alcohol consumption affect how Boots Threadworm works?

A: Official product information notes that the use of alcohol, tobacco, or certain foods with this medicine is a matter for discussion with a healthcare professional. This is a general caution often mentioned in regulatory documents.

Q: What happens if I miss the time for the second dose (if two are required)?

A: According to general guidelines for missed doses, if a dose is missed, regulatory guidance suggests taking it as soon as possible. If it is almost time for the next scheduled dose, the guidance advises skipping the missed dose. It is advised not to double the dose to make up for a missed one.

Q: Does Boots Threadworm interact with any common herbal supplements?

A: Regulatory documents state that there is limited available information on taking mebendazole with herbal remedies or supplements. This is because these products are often not tested for drug interactions in the same way as authorized prescription medicines.

Q: Are there any known interactions with birth control pills?

A: Official information indicates that mebendazole does not reduce the effectiveness of hormonal birth control pills. However, if the medicine causes severe vomiting or diarrhea that lasts for more than 24 hours, contraceptive protection may be reduced.

Q: Does Boots Threadworm interact with common vitamins or minerals?

A: As with herbal supplements, official safety data has limited information regarding the interaction of mebendazole with common vitamins or minerals. Product labels note that consulting a healthcare professional about all supplements being taken is recommended before treatment.

Q: Can someone take Boots Threadworm if they are already taking a regular prescription medicine?

A: Official advice strongly recommends informing a healthcare professional about all medicines being taken prior to treatment. This includes all prescriptions, over-the-counter medicines, herbal remedies, vitamins, or supplements.

Q: Does the drug's active ingredient stay in the body for a long time?

A: The time it takes for the active ingredient to clear from the body is measured by its elimination half-life. Studies have reported that the elimination half-life of mebendazole ranges from approximately 2.8 to 9.0 hours.

Q: Does the medicine have a known interaction with grapefruit juice?

A: Official safety information reviewed for the active ingredient mebendazole indicates that there is no reported interaction with grapefruit juice.

Q: What is the duration of the threadworm infection if left untreated?

A: Based on public health guidance, a threadworm infection is generally considered self-limiting. The infection cycle typically breaks down within 6 weeks, provided that re-ingestion of eggs is consistently prevented through hygiene measures.

Q: Can people with kidney or liver issues use Boots Threadworm?

A: Official documents emphasize that special attention should be given to patients with existing liver disease before starting treatment. Official documents indicate that patients with existing liver or kidney issues may require careful monitoring of their liver (hepatic) and kidney (renal) function following treatment.

Q: Do studies suggest Boots Threadworm is well-tolerated by most people?

A: Official product information and studies indicate that the active ingredient, mebendazole, is generally well tolerated when taken at the recommended dose.

Q: Why is it described as treating 'threadworms' and not other parasites?

A: While the active ingredient is an anthelmintic (anti-worm drug) with a broader range of action, the product is primarily indicated for threadworm (pinworm) as an over-the-counter medicine. Its use for treating other types of worms is usually restricted to circumstances requiring medical supervision.

How to Store and Dispose of Boots Threadworm

The storage and disposal of Boots Threadworm Tablets (Mebendazole) are governed by official regulatory standards to ensure product stability and environmental safety.

Storage Conditions and Safety

Official documents indicate that the product generally does not require any special temperature conditions, but should be stored at controlled room temperature, away from excessive heat and freezing. To maintain product stability, the tablets must be kept in their original blister and outer carton to protect them from moisture and light.

For safety, the medicine must always be kept out of the sight and reach of children.

Disposal Instructions

Boots Threadworm Tablets must not be thrown away with household waste or disposed of via wastewater, as required by environmental protection guidelines. Unused or expired medication should be returned to a pharmacy or discarded according to local regulatory requirements to ensure proper pharmaceutical waste handling.